Financial highlights The financial information in this review represents the year-end position for the Cell Therapy Catapult Limited group for the year ending 31st March 2021. For the year ended 31st March 2021 2021 £’000s 2020 £’000s 2019 £’000s Innovate UK core grant funding 14,200 15,800 26,800 Third party grant funding 34,500 8,100 4,500 Industrial income 21,200 14,900 7,000 Total 69,900 38,800 38,300 Income For the year ended 31st March 2021 2021 £’000s 2020 £’000s 2019 £’000s Fixed assets 74,600 56,300 53,200 Net current assets 28,300 12,500 9,800 Creditors (17,100) (7,000) (7,000) Provisions for liabilities (13,600) (10,300) (8,700) Net assets 72,200 51,500 47,300 Capital and reserves 72,200 51,500 47,300 Balance sheet Cell and Gene Therapy Catapult is the trading name of Cell Therapy Catapult Limited (limited by guarantee), registered in England and Wales under company number 08964711 with registered office at 12th Floor Tower Wing B, Guy’s Hospital, Great Maze Pond, London SE1 9RT.